ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2223

Relationship Between Sleep Quality, Disease Activity, and Psychological Factors in Patients with Axial Spondyloarthritis: A Cross Sectional Study

Srujana Budumuru, Rohini Handa, Sundeep Kumar Upadhyaya, Sirinder Jit Gupta, Meera H Shah, Meera P Shah and Anushka Aggarwal, Indraprastha Apollo Hospital, Delhi, India

Meeting: ACR Convergence 2023

Keywords: Demographics, depression, Patient reported outcomes, sleep, spondyloarthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 14, 2023

Title: (2195–2226) Spondyloarthritis Including Psoriatic Arthritis – Diagnosis, Manifestations, & Outcomes Poster III: SpA

Session Type: Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: Sleep problems are prevalent in 30-70% of patients with axial Spondyloarthritis (SpA), negatively impacting their quality of life. Poor sleep quality in these patients has been associated with reduced exercise tolerance, worsened pain and fatigue, decreased functional status, and compromised response to therapy. While previous studies have explored the determinants of sleep problems in axial SpA patients, our study is the first in India to assess sleep quality and its components, as well as the influence of various factors on sleep in this population.

Methods: This prospective, cross-sectional study was conducted from March 2021 to September 2022 at the Department of Rheumatology, Indraprastha Apollo Hospital, Delhi. A total of 119 axial SpA patients participated, and sleep quality was measured using the PSQI questionnaire. Bivariate correlations were performed to examine the relationships between sleep quality (PSQI score) and various factors, including age, gender, disease duration, inflammatory markers, quality of life, disease activity, functionality, spinal mobility, anxiety, depression, fatigue, pain, socioeconomic status, and biological usage. Significant variables were included in a multiple linear regression model. Additionally, univariate analysis compared baseline variables and disease activity between patients with good sleep quality (PSQI < 5) and poor sleep quality (PSQI ≥ 5).

Results: Among the participants, 53% experienced poor sleep quality, with a mean global PSQI score of 5.54±4.03. As many as, 73% were not receiving treatment for insomnia. Patients with poor sleep quality had significantly higher scores across all seven dimensions of the PSQI. Sleep latency and subjective sleep quality were the most affected components, while the use of sleep medication was the least affected. Factors associated with poor sleep quality included older age, longer disease duration, smoking, radiographic evidence of sacroiliitis, hip disease, elevated inflammatory markers, low back pain, fatigue, high disease activity, poor functional status, increased spinal mobility limitation, anxiety, and depression (table 1). Gender, socioeconomic status, use of conventional DMARDs and biological therapy, enthesitis, and daytime sleepiness did not significantly influence sleep quality. Multivariate analysis revealed that limitations in spinal and hip mobility (OR: 3.76 [1.53-9.24]), fatigue (OR: 1.99 [1.27-3.11]), and depression (OR: 1.63 [1.10-2.41]) were independent risk factors for poor sleep quality.

Conclusion: Our study highlights the high prevalence of poor sleep quality in patients with axial SpA, despite limited utilization of insomnia treatments. Emotional factors such as fatigue and depression, as well as limitations in spinal and hip mobility, were identified as contributors to sleep problems in these patients. The complex relationship between sleep quality, emotional disorders, and disease activity underscores the importance of a multidisciplinary approach to managing axial SpA.

Supporting image 1

Correlation coefficients between the PSQI and demographic, clinical variables and PROs and index of disease activity, functionality, and Metric indices


Disclosures: S. Budumuru: None; R. Handa: None; S. Upadhyaya: None; S. Gupta: None; M. Shah: None; M. Shah: None; A. Aggarwal: None.

To cite this abstract in AMA style:

Budumuru S, Handa R, Upadhyaya S, Gupta S, Shah M, Shah M, Aggarwal A. Relationship Between Sleep Quality, Disease Activity, and Psychological Factors in Patients with Axial Spondyloarthritis: A Cross Sectional Study [abstract]. Arthritis Rheumatol. 2023; 75 (suppl 9). https://acrabstracts.org/abstract/relationship-between-sleep-quality-disease-activity-and-psychological-factors-in-patients-with-axial-spondyloarthritis-a-cross-sectional-study/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2023

ACR Meeting Abstracts - https://acrabstracts.org/abstract/relationship-between-sleep-quality-disease-activity-and-psychological-factors-in-patients-with-axial-spondyloarthritis-a-cross-sectional-study/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology